The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $77.92

Today's change0.00 0.00%
Updated August 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $77.92

Today's change0.00 0.00%
Updated August 30 4:00 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc closed at (U.S.)$77.92.

Over the last five days, shares have lost 4.36% and are down 23.00% for the last year to date. This security has underperformed the S&P 500 by 37.12% during the last year.

Key company metrics

  • Open(U.S.) $78.05
  • Previous close(U.S.) $77.92
  • High(U.S.) $78.39
  • Low(U.S.) $77.66
  • Bid / Ask(U.S.) $77.84 / (U.S.) $77.99
  • YTD % change-23.00%
  • Volume9,174,195
  • Average volume (10-day)9,452,316
  • Average volume (1-month)11,751,403
  • Average volume (3-month)10,264,906
  • 52-week range(U.S.) $77.63 to (U.S.) $113.31
  • Beta1.06
  • Trailing P/E6.86×
  • P/E 1 year forward6.64×
  • Forward PEG83.36×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.41%
  • Trailing EPS(U.S.) $11.35
Updated August 30 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue7,7767,7948,5068,295
Total other revenue--------
Total revenue7,7767,7948,5068,295
Gross profit6,9126,6017,4447,231
Total cost of revenue8641,1931,0621,064
Total operating expense3,2383,1432,8852,710
Selling / general / administrative8906851,066903
Research & development1,4841,265757743
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,5384,6515,6215,585
Interest income (expense), net non-operating-227-230-230-165
Gain (loss) on sale of assets--------
Other--------
Income before tax4,3994,5025,4375,472
Income after tax3,4973,5674,6854,592
Income tax, total902935752880
Net income3,4973,5664,6834,600
Total adjustments to net income--------
Net income before extra. items3,4973,5664,6834,600
Minority interest0-1-28
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,4973,5664,6834,600
Inc. avail. to common incl. extra. items3,4973,5664,6834,600
Diluted net income3,4973,5664,6834,600
Dilution adjustment000--
Diluted weighted average shares1,3551,4121,4701,503
Diluted EPS excluding extraordinary itemsvalue per share2.582.533.193.06
Dividends per sharevalue per share0.470.430.430.43
Diluted normalized EPSvalue per share2.582.533.193.06